β³ Fetching live dividend data...
Home βΊ Calculator βΊ QGEN Dividend Calculator 2026
Qiagen N.V. Β· NYSE
Price: $50.37 Β· Annual div: $2.64/share Β· Frequency: semi-annual Β· Payout ratio: 129% Β· Ex-div: 2026-07-07
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2026-07-07Latest | 2026-07-14 | $0.3500 | 6.75% | $39.13 |
| 2026-01-08 | β | $2.2900 | 8.06% | $47.57 |
| 2025-07-02 | 2025-07-10 | $0.2500 | 3.21% | $48.21 |
| 2025-01-29 | 2025-01-29 | $1.2960 | 2.98% | $43.50 |
| 2024-01-30 | 2024-01-31 | $1.3578 | 3.09% | $43.98 |
| 2017-01-25 | β | $1.1452 | β | β |
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.
Forward dividend yield from the latest data Β· open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open QGEN position with:
Real after-tax yield depends on where you live and how you hold QGEN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 5.24% | 2.44% | $524 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 4.45% | 1.65% | $445 / yr |
| πΊπΈ US Taxable (20%) | 20% | 4.19% | 1.39% | $419 / yr |
| π¬π§ UK ISA | 0% | 5.24% | 2.44% | $524 / yr |
| π¬π§ UK Taxable | 8.75% | 4.78% | 1.98% | $478 / yr |
| π¨π¦ TFSA | 0% | 5.24% | 2.44% | $524 / yr |
| π¨π¦ CA Taxable | 25% | 3.93% | 1.13% | $393 / yr |
| π¦πΊ Super (pension) | 15% | 4.45% | 1.65% | $445 / yr |
| π¦πΊ AU Taxable | 30% | 3.67% | 0.87% | $367 / yr |
| π©πͺ DE Taxable | 26.375% | 3.86% | 1.06% | $386 / yr |
| π«π· FR Taxable | 30% | 3.67% | 0.87% | $367 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.64/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
QGEN pays quarterly β 4 times per year. Ex-div: 2026-07-07.
How QGEN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for QGEN sourced from FMP /financial-growth endpoint β real data, not estimates.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Compare QGEN with peers: QGEN vs ALGN Β· QGEN vs BAX Β· QGEN vs BMRN
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the QGEN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Qiagen N.V. (QGEN) is currently trading at $50.37, 13% below its 52-week high. The current dividend yield is 5.24% based on an annual payout of $2.64 per share.
Qiagen N.V. (QGEN) is a healthcare stock currently trading at $50.37 with a dividend yield of 5.24%. It pays an annual dividend of $2.64 per share. The payout ratio of 129% indicates investors should monitor dividend sustainability.
Auto-generated from live market data. For educational purposes only β not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team β not customer reviews.
QGEN (Qiagen N.V.) has a dividend yield of 5.24%, based on an annual dividend of $2.64 per share and a price of $50.37. Over the last 12 months it paid $2.64 per share β a trailing yield of 5.24%. Dividends are paid semi-annual.
Yield history: over the last 5 payments, QGEN's 12-month yield ranged from 2.98% to 8.06%. Full QGEN dividend history β
With dividends reinvested, a QGEN position grows its share count by about 5.06% in the first year at today's price and yield. If the dividend grows 0.0% a year and the price 3.5%, DRIP doubles your number of shares in about 19 years without adding new money.
| Year | Shares bought by dividends | Total shares | Dividend income | Position value | Yield on cost |
|---|---|---|---|---|---|
| 1 | 10.05 | 208.58 | $524 | $10,874 | 5.24% |
| 3 | 10.34 | 229.13 | $578 | $12,796 | 5.78% |
| 5 | 10.57 | 250.17 | $633 | $14,966 | 6.33% |
| 10 | 10.90 | 304.15 | $774 | $21,610 | 7.74% |
| 20 | 10.58 | 412.32 | $1,061 | $41,325 | 10.61% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work β
QGEN (Qiagen N.V.) has a dividend yield of 5.24%, based on an annual dividend of $2.64 per share and a price of $50.37. Over the last 12 months it paid $2.64 per share β a trailing yield of 5.24%. Dividends are paid semi-annual.
$10,000 in QGEN at a 5.24% yield pays about $524 a year ($44 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a QGEN position grows its share count by about 5.06% in the first year at today's price and yield. If the dividend grows 0.0% a year and the price 3.5%, DRIP doubles your number of shares in about 19 years without adding new money.
Enter your starting amount, monthly contribution and time horizon in the QGEN DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
QGEN's next ex-dividend date has not been announced yet; the most recent one was 2026-07-07. QGEN pays dividends semi-annual. Buy before the ex-dividend date to receive the next payment.
QGEN's dividend changed 70.8% over the last year and 0.0% a year on average over five years.
QGEN pays out 129% of its earnings as dividends. A payout ratio above 80% means the dividend depends on earnings holding up. Dividends can be cut at any time; this is not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever